{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:25:45Z","timestamp":1781785545816,"version":"3.54.5"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE_00000019 \u201cHEAL ITALIA\u201d"],"award-info":[{"award-number":["PE_00000019 \u201cHEAL ITALIA\u201d"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007359","name":"Fondazione Banco di Sardegna","doi-asserted-by":"publisher","award":["40974"],"award-info":[{"award-number":["40974"]}],"id":[{"id":"10.13039\/100007359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-97406-4","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T15:03:24Z","timestamp":1744902204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Human leukocyte antigen-G in hepatocellular carcinoma driven by chronic viral hepatitis or steatotic liver disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Stefano","family":"Mocci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Perra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Littera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Mascia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Murgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mereu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Lorrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Du\u015b-Ilnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Zedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Giuressi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Miglianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Stradoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Zolfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luchino","family":"Chessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"97406_CR1","unstructured":"Liver cancer statistics. World Health Organization https:\/\/www.wcrf.org\/preventing-cancer\/cancer-statistics\/liver-cancer-statistics\/page\/17\/ (2025)."},{"key":"97406_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 7, 6 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"97406_CR3","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag, H. B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142, 1264-1273.e1 (2012).","journal-title":"Gastroenterology"},{"key":"97406_CR4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.7326\/0003-4819-148-11-200806030-00004","volume":"148","author":"H Tanaka","year":"2008","unstructured":"Tanaka, H. et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann. Intern. Med. 148, 820\u2013826 (2008).","journal-title":"Ann. Intern. Med."},{"key":"97406_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ijc.23911","volume":"124","author":"D Qiu","year":"2009","unstructured":"Qiu, D., Katanoda, K., Marugame, T. & Sobue, T. A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958\u20132004). Int. J. Cancer 124, 443\u2013448 (2009).","journal-title":"Int. J. Cancer"},{"key":"97406_CR6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal, A. G., Kanwal, F. & Llovet, J. M. Global trends in hepatocellular carcinoma epidemiology: Implications for screening, prevention and therapy. Nat. Rev. Clin. Oncol. 20, 864\u2013884 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"97406_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/liv.14735","volume":"41","author":"F Garuti","year":"2021","unstructured":"Garuti, F. et al. The changing scenario of hepatocellular carcinoma in Italy: An update. Liver Int. 41, 585\u2013597 (2021).","journal-title":"Liver Int."},{"key":"97406_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1159\/000538301","volume":"13","author":"BG Song","year":"2024","unstructured":"Song, B. G. et al. Risk of hepatocellular carcinoma by steatotic liver disease and its newly proposed subclassification. Liver Cancer 13, 561\u2013571 (2024).","journal-title":"Liver Cancer"},{"key":"97406_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.601710","volume":"10","author":"D Suresh","year":"2020","unstructured":"Suresh, D., Srinivas, A. N. & Kumar, D. P. Etiology of hepatocellular carcinoma: Special focus on fatty liver disease. Front. Oncol. 10, 601710 (2020).","journal-title":"Front. Oncol."},{"key":"97406_CR10","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986 (2023).","journal-title":"Hepatology"},{"key":"97406_CR11","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s, P. et al. Liver cirrhosis. Lancet 398, 1359\u20131376 (2021).","journal-title":"Lancet"},{"key":"97406_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/JHC.S168682","volume":"6","author":"O Elshaarawy","year":"2019","unstructured":"Elshaarawy, O., Gomaa, A., Omar, H., Rewisha, E. & Waked, I. Intermediate stage hepatocellular carcinoma: A summary review. J. Hepatocell. Carcinoma 6, 105\u2013117 (2019).","journal-title":"J. Hepatocell. Carcinoma"},{"key":"97406_CR13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi, H. et al. Global burden of liver disease: 2023 update. J. Hepatol. 79, 516\u2013537 (2023).","journal-title":"J. Hepatol."},{"key":"97406_CR14","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/ajg.2013.160","volume":"108","author":"TM Welzel","year":"2013","unstructured":"Welzel, T. M. et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am. J. Gastroenterol. 108, 1314\u20131321 (2013).","journal-title":"Am. J. Gastroenterol."},{"key":"97406_CR15","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1038\/s41598-018-26217-7","volume":"8","author":"H Sawai","year":"2018","unstructured":"Sawai, H. et al. Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma. Sci. Rep. 8, 7958 (2018).","journal-title":"Sci. Rep."},{"key":"97406_CR16","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jhep.2015.03.007","volume":"62","author":"L Amiot","year":"2015","unstructured":"Amiot, L., Vu, N. & Samson, M. Biology of the immunomodulatory molecule HLA-G in human liver diseases. J. Hepatol. 62, 1430\u20131437 (2015).","journal-title":"J. Hepatol."},{"key":"97406_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0065-2776(03)81006-4","volume":"81","author":"ED Carosella","year":"2003","unstructured":"Carosella, E. D. et al. HLA-G molecules: From maternal-fetal tolerance to tissue acceptance. Adv. Immunol. 81, 199\u2013252 (2003).","journal-title":"Adv. Immunol."},{"key":"97406_CR18","first-page":"273","volume":"31","author":"A Champsaur","year":"1986","unstructured":"Champsaur, A., Amamou, R., Nefzi, A. & Marichy, J. Use of duoderm in the treatment of skin graft donor sites. comparative study of duoderm and tulle gras. Ann. Chir. Plast. Esthet. 31, 273\u2013278 (1986).","journal-title":"Ann. Chir. Plast. Esthet."},{"key":"97406_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00018-010-0580-7","volume":"68","author":"EA Donadi","year":"2011","unstructured":"Donadi, E. A. et al. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell. Mol. Life Sci. 68, 369\u2013395 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"97406_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169032","volume":"12","author":"I Poras","year":"2017","unstructured":"Poras, I. et al. Haplotypes of the HLA-G 3\u2019 untranslated region respond to endogenous factors of HLA-G+ and HLA-G- cell lines differentially. PLoS ONE 12, e0169032 (2017).","journal-title":"PLoS ONE"},{"key":"97406_CR21","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.1038\/s41598-019-41900-z","volume":"9","author":"E Schwich","year":"2019","unstructured":"Schwich, E. et al. HLA-G 3\u2019 untranslated region variants +3187G\/G, +3196G\/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer. Sci. Rep. 9, 5407 (2019).","journal-title":"Sci. Rep."},{"key":"97406_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/tan.13909","volume":"96","author":"JJM Drabbels","year":"2020","unstructured":"Drabbels, J. J. M. et al. HLA-G whole gene amplification reveals linkage disequilibrium between the HLA-G 3\u2019UTR and coding sequence. HLA 96, 179\u2013185 (2020).","journal-title":"HLA"},{"key":"97406_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","volume":"127","author":"ED Carosella","year":"2015","unstructured":"Carosella, E. D., Rouas-Freiss, N., Tronik-Le Roux, D., Moreau, P. & LeMaoult, J. HLA-G: An immune checkpoint molecule. Adv. Immunol. 127, 33\u2013144 (2015).","journal-title":"Adv. Immunol."},{"key":"97406_CR24","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3389\/fimmu.2020.01613","volume":"11","author":"P Contini","year":"2020","unstructured":"Contini, P., Murdaca, G., Puppo, F. & Negrini, S. HLA-G expressing immune cells in immune mediated diseases. Front. Immunol. 11, 1613 (2020).","journal-title":"Front. Immunol."},{"key":"97406_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3389\/fimmu.2016.00653","volume":"7","author":"S Gregori","year":"2016","unstructured":"Gregori, S. Editorial: HLA-G-mediated immune tolerance: Past and new outlooks. Front. Immunol. 7, 653 (2016).","journal-title":"Front. Immunol."},{"key":"97406_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.826074","volume":"13","author":"S Jasinski-Bergner","year":"2022","unstructured":"Jasinski-Bergner, S., Schmiedel, D., Mandelboim, O. & Seliger, B. Role of HLA-G in viral infections. Front. Immunol. 13, 826074 (2022).","journal-title":"Front. Immunol."},{"key":"97406_CR27","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3389\/fimmu.2014.00592","volume":"5","author":"R Rizzo","year":"2014","unstructured":"Rizzo, R., Bortolotti, D., Bolzani, S. & Fainardi, E. HLA-G molecules in autoimmune diseases and infections. Front. Immunol. 5, 592 (2014).","journal-title":"Front. Immunol."},{"key":"97406_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/693643","volume":"2013","author":"F Celsi","year":"2013","unstructured":"Celsi, F. et al. HLA-G\/C, miRNAs, and their role in HIV infection and replication. Biomed. Res. Int. 2013, 693643 (2013).","journal-title":"Biomed. Res. Int."},{"key":"97406_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jhep.2013.09.006","volume":"60","author":"L Amiot","year":"2014","unstructured":"Amiot, L. et al. Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis. J. Hepatol. 60, 245\u2013252 (2014).","journal-title":"J. Hepatol."},{"key":"97406_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1365-2893.2010.01286.x","volume":"18","author":"FJ Souto","year":"2011","unstructured":"Souto, F. J. et al. Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection. J. Viral Hepat. 18, 102\u2013105 (2011).","journal-title":"J. Viral Hepat."},{"key":"97406_CR31","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.humimm.2011.06.012","volume":"72","author":"WW Shi","year":"2011","unstructured":"Shi, W. W. et al. Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection. Hum. Immunol. 72, 1068\u20131073 (2011).","journal-title":"Hum. Immunol."},{"key":"97406_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.humimm.2011.02.008","volume":"72","author":"PJ Weng","year":"2011","unstructured":"Weng, P. J. et al. Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection. Hum. Immunol. 72, 406\u2013411 (2011).","journal-title":"Hum. Immunol."},{"key":"97406_CR33","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.4081\/ejh.2016.2606","volume":"60","author":"G Caocci","year":"2016","unstructured":"Caocci, G. et al. HLA-G expression and role in advanced-stage classical Hodgkin lymphoma. Eur. J. Histochem. 60, 2606 (2016).","journal-title":"Eur. J. Histochem."},{"key":"97406_CR34","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1182\/blood-2012-03-416792","volume":"120","author":"R Brown","year":"2012","unstructured":"Brown, R. et al. CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis. Blood 120, 2055\u20132063 (2012).","journal-title":"Blood"},{"key":"97406_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.humimm.2019.10.003","volume":"81","author":"D Bortolotti","year":"2020","unstructured":"Bortolotti, D., Gentili, V., Rotola, A., Potena, L. & Rizzo, R. Soluble HLA-G pre-transplant levels to identify the risk for development of infection in heart transplant recipients. Hum. Immunol. 81, 147\u2013150 (2020).","journal-title":"Hum. Immunol."},{"key":"97406_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.humimm.2020.02.006","volume":"81","author":"A Ajith","year":"2020","unstructured":"Ajith, A. et al. HLA-G and humanized mouse models as a novel therapeutic approach in transplantation. Hum. Immunol. 81, 178\u2013185 (2020).","journal-title":"Hum. Immunol."},{"key":"97406_CR37","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/medicina57101007","volume":"57","author":"SW Kang","year":"2021","unstructured":"Kang, S. W. et al. HLA-G 14bp Ins\/del polymorphism in the 3\u2019UTR region and acute rejection in kidney transplant recipients: An updated meta-analysis. Medicina (Kaunas) 57, 1007 (2021).","journal-title":"Medicina (Kaunas)"},{"key":"97406_CR38","first-page":"119","volume":"140","author":"VV Agadzhanian","year":"1988","unstructured":"Agadzhanian, V. V. & Kravtsov, S. A. Hemosorption in the complex treatment of patients with suppurative arthritis. Vestn. Khir. Im. I I Grek. 140, 119\u2013123 (1988).","journal-title":"Vestn. Khir. Im. I I Grek."},{"key":"97406_CR39","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.5301\/jn.5000252","volume":"26","author":"R Littera","year":"2013","unstructured":"Littera, R. et al. Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes. J Nephrol 26, 1170\u20131178 (2013).","journal-title":"J Nephrol"},{"key":"97406_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/10408363.2012.677947","volume":"49","author":"A Gonz\u00e1lez","year":"2012","unstructured":"Gonz\u00e1lez, A. et al. The immunosuppressive molecule HLA-G and its clinical implications. Crit. Rev. Clin. Lab. Sci. 49, 63\u201384 (2012).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"97406_CR41","doi-asserted-by":"publisher","first-page":"1007647","DOI":"10.3389\/fimmu.2022.1007647","volume":"13","author":"R Littera","year":"2022","unstructured":"Littera, R. et al. The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis. Front. Immunol. 13, 1007647 (2022).","journal-title":"Front. Immunol."},{"key":"97406_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.597468","volume":"10","author":"L Liu","year":"2020","unstructured":"Liu, L., Wang, L., Zhao, L., He, C. & Wang, G. The role of HLA-G in tumor escape: Manipulating the phenotype and function of immune cells. Front. Oncol. 10, 597468 (2020).","journal-title":"Front. Oncol."},{"key":"97406_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1499-3872(11)60025-8","volume":"10","author":"Y Wang","year":"2011","unstructured":"Wang, Y., Ye, Z., Meng, X. Q. & Zheng, S. S. Expression of HLA-G in patients with hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int. 10, 158\u2013163 (2011).","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"97406_CR44","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1111\/j.1582-4934.2009.00917.x","volume":"14","author":"A Lin","year":"2010","unstructured":"Lin, A. et al. Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma. J. Cell. Mol. Med. 14, 2162\u20132171 (2010).","journal-title":"J. Cell. Mol. Med."},{"key":"97406_CR45","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.7150\/jca.29655","volume":"10","author":"XK Wang","year":"2019","unstructured":"Wang, X. K. et al. Diagnostic and prognostic biomarkers of Human Leukocyte Antigen complex for hepatitis B virus-related hepatocellular carcinoma. J. Cancer 10, 5173\u20135190 (2019).","journal-title":"J. Cancer"},{"key":"97406_CR46","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/tan.12097","volume":"81","author":"AC Teixeira","year":"2013","unstructured":"Teixeira, A. C. et al. The 14bp-deletion allele in the HLA-G gene confers susceptibility to the development of hepatocellular carcinoma in the Brazilian population. Tissue Antigens 81, 408\u2013413 (2013).","journal-title":"Tissue Antigens"},{"key":"97406_CR47","doi-asserted-by":"publisher","first-page":"e16067","DOI":"10.1097\/MD.0000000000016067","volume":"98","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y., Li, W., Lu, J., Zhao, X. & Li, L. HLA-G +3142 C>G polymorphism and cancer risk: Evidence from a meta-analysis and trial sequential analysis. Medicine (Baltimore) 98, e16067 (2019).","journal-title":"Medicine (Baltimore)"},{"key":"97406_CR48","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach, J. K. et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67, 358\u2013380 (2018).","journal-title":"Hepatology"},{"key":"97406_CR49","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/tan.13342","volume":"92","author":"LL Nilsson","year":"2018","unstructured":"Nilsson, L. L., Funck, T., Kjersgaard, N. D. & Hviid, T. V. F. Next-generation sequencing of HLA-G based on long-range polymerase chain reaction. HLA 92, 144\u2013153 (2018).","journal-title":"HLA"},{"key":"97406_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09986","volume":"8","author":"S Dhouioui","year":"2022","unstructured":"Dhouioui, S., Boujelbene, N., Ouzari, H. I., Tizaoui, K. & Zidi, I. Meta-analysis of HLA-G 14bp insertion\/deletion polymorphism and soluble HLA-G revealed an association with digestive cancers initiation and prognosis. Heliyon 8, e09986 (2022).","journal-title":"Heliyon"},{"key":"97406_CR51","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1007\/s13277-015-3669-7","volume":"37","author":"X Bian","year":"2016","unstructured":"Bian, X. et al. Down-expression of miR-152 lead to impaired anti-tumor effect of NK via upregulation of HLA-G. Tumour Biol. 37, 3749\u20133756 (2016).","journal-title":"Tumour Biol."},{"key":"97406_CR52","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1017\/S0029665109990206","volume":"68","author":"IS Wood","year":"2009","unstructured":"Wood, I. S., de Heredia, F. P., Wang, B. & Trayhurn, P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc. Nutr. Soc. 68, 370\u2013377 (2009).","journal-title":"Proc. Nutr. Soc."},{"key":"97406_CR53","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2174\/187152812803590037","volume":"11","author":"R Rizzo","year":"2012","unstructured":"Rizzo, R., Bortolotti, D., Baricordi, O. R. & Fainardi, E. New insights into HLA-G and inflammatory diseases. Inflamm. Allergy Drug Targets 11, 448\u2013463 (2012).","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"97406_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.humimm.2007.11.001","volume":"69","author":"S Rosado","year":"2008","unstructured":"Rosado, S. et al. Expression of human leukocyte antigen-G in systemic lupus erythematosus. Hum. Immunol. 69, 9\u201315 (2008).","journal-title":"Hum. Immunol."},{"key":"97406_CR55","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1399-0039.2008.01037.x","volume":"71","author":"R Rizzo","year":"2008","unstructured":"Rizzo, R. et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 71, 520\u2013529 (2008).","journal-title":"Tissue Antigens"},{"key":"97406_CR56","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3899\/jrheum.080552","volume":"36","author":"IJ Wastowski","year":"2009","unstructured":"Wastowski, I. J. et al. HLA-G expression in the skin of patients with systemic sclerosis. J. Rheumatol. 36, 1230\u20131234 (2009).","journal-title":"J. Rheumatol."},{"key":"97406_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/232390","volume":"2012","author":"JF de Carvalho","year":"2012","unstructured":"de Carvalho, J. F. et al. Heparin increases HLA-G levels in primary antiphospholipid syndrome. Clin. Dev. Immunol. 2012, 232390 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"97406_CR58","doi-asserted-by":"publisher","first-page":"63690","DOI":"10.18632\/oncotarget.11628","volume":"7","author":"L Yaghi","year":"2016","unstructured":"Yaghi, L. et al. Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2. Oncotarget 7, 63690\u201363707 (2016).","journal-title":"Oncotarget"},{"key":"97406_CR59","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1111\/j.1582-4934.2009.00917.x","volume":"14","author":"A Lin","year":"2010","unstructured":"Lin, A. et al. Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma. J. Cell. Mol. Med. 14, 2162\u20132171 (2010).","journal-title":"J. Cell. Mol. Med."},{"key":"97406_CR60","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1158\/1078-0432.CCR-09-0463","volume":"15","author":"MY Cai","year":"2009","unstructured":"Cai, M. Y. et al. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin. Cancer Res. 15, 4686\u20134693 (2009).","journal-title":"Clin. Cancer Res."},{"key":"97406_CR61","doi-asserted-by":"publisher","first-page":"7021","DOI":"10.1182\/blood-2010-07-294389","volume":"117","author":"S Agaugu\u00e9","year":"2011","unstructured":"Agaugu\u00e9, S., Carosella, E. D. & Rouas-Freiss, N. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1\/Th17. Blood 117, 7021\u20137031 (2011).","journal-title":"Blood"},{"key":"97406_CR62","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1002\/ijc.28845","volume":"135","author":"L Loumagne","year":"2014","unstructured":"Loumagne, L. et al. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance. Int. J. Cancer 135, 2107\u20132117 (2014).","journal-title":"Int. J. Cancer"},{"key":"97406_CR63","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s12094-019-02244-2","volume":"22","author":"AD L\u00e1zaro-S\u00e1nchez","year":"2020","unstructured":"L\u00e1zaro-S\u00e1nchez, A. D. et al. HLA-G as a new tumor biomarker: detection of soluble isoforms of HLA-G in the serum and saliva of patients with colorectal cancer. Clin. Transl. Oncol. 22, 1166\u20131171 (2020).","journal-title":"Clin. Transl. Oncol."},{"key":"97406_CR64","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/s41598-020-60811-y","volume":"10","author":"V Agnihotri","year":"2020","unstructured":"Agnihotri, V., Gupta, A., Kumar, L. & Dey, S. Serum sHLA-G: Significant diagnostic biomarker with respect to therapy and immunosuppressive mediators in head and neck squamous cell carcinoma. Sci. Rep. 10, 3806 (2020).","journal-title":"Sci. Rep."},{"key":"97406_CR65","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3389\/fimmu.2017.00832","volume":"8","author":"NB Crux","year":"2017","unstructured":"Crux, N. B. & Elahi, S. Human leukocyte antigen (HLA) and immune regulation: How do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections. Front. Immunol. 8, 832 (2017).","journal-title":"Front. Immunol."},{"key":"97406_CR66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","volume":"23","author":"YT Chan","year":"2024","unstructured":"Chan, Y. T. et al. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Mol. Cancer 23, 189 (2024).","journal-title":"Mol. Cancer"},{"key":"97406_CR67","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","volume":"28","author":"H Hanif","year":"2022","unstructured":"Hanif, H. et al. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J. Gastroenterol. 28, 216\u2013229 (2022).","journal-title":"World J. Gastroenterol."},{"key":"97406_CR68","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.3390\/cancers13174334","volume":"13","author":"P Maravelia","year":"2021","unstructured":"Maravelia, P. et al. Liquid biopsy in hepatocellular carcinoma: opportunities and challenges for immunotherapy. Cancers (Basel) 13, 4334 (2021).","journal-title":"Cancers (Basel)"},{"key":"97406_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071742","volume":"8","author":"G Martelli-Palomino","year":"2013","unstructured":"Martelli-Palomino, G. et al. Polymorphic sites at the 3\u2019 untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population. PLoS ONE 8, e71742 (2013).","journal-title":"PLoS ONE"},{"key":"97406_CR70","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3389\/fimmu.2020.01178","volume":"11","author":"G Amodio","year":"2020","unstructured":"Amodio, G. & Gregori, S. HLA-G genotype\/expression\/disease association studies: Success, hurdles, and perspectives. Front. Immunol. 11, 1178 (2020).","journal-title":"Front. Immunol."},{"key":"97406_CR71","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1089\/dna.2011.1238","volume":"30","author":"Y Jiang","year":"2011","unstructured":"Jiang, Y. et al. Association of HLA-G 3\u2019 UTR 14-bp insertion\/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population. DNA Cell Biol. 30, 1027\u20131032 (2011).","journal-title":"DNA Cell Biol."},{"key":"97406_CR72","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/iji.12636","volume":"50","author":"JD Oliveira Correa","year":"2023","unstructured":"Oliveira Correa, J. D. et al. HLA-G 3\u2019UTR haplotype analyses in HCV infection and HCV-derived cirrhosis, hepatocellular carcinoma and fibrosis. Int. J. Immunogenet. 50, 249\u2013255 (2023).","journal-title":"Int. J. Immunogenet."},{"key":"97406_CR73","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.humimm.2013.03.003","volume":"74","author":"SG Svendsen","year":"2013","unstructured":"Svendsen, S. G. et al. The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3\u2019-untranslated region. Hum. Immunol. 74, 818\u2013827 (2013).","journal-title":"Hum. Immunol."},{"key":"97406_CR74","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.molimm.2015.01.030","volume":"65","author":"IO Porto","year":"2015","unstructured":"Porto, I. O. et al. MicroRNAs targeting the immunomodulatory HLA-G gene: a new survey searching for microRNAs with potential to regulate HLA-G. Mol. Immunol. 65, 230\u2013241 (2015).","journal-title":"Mol. Immunol."},{"key":"97406_CR75","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1086\/521200","volume":"81","author":"Z Tan","year":"2007","unstructured":"Tan, Z. et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am. J. Hum. Genet. 81, 829\u2013834 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"97406_CR76","doi-asserted-by":"publisher","first-page":"7138","DOI":"10.1093\/nar\/gki1012","volume":"33","author":"C Barreau","year":"2005","unstructured":"Barreau, C., Paillard, L. & Osborne, H. B. AU-rich elements and associated factors: Are there unifying principles. Nucleic Acids Res. 33, 7138\u20137150 (2005).","journal-title":"Nucleic Acids Res."},{"key":"97406_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058032","volume":"8","author":"NL Podnecky","year":"2013","unstructured":"Podnecky, N. L. et al. Comparison of DNA extraction kits for detection of Burkholderia pseudomallei in spiked human whole blood using real-time PCR. PLoS ONE 8, e58032 (2013).","journal-title":"PLoS ONE"},{"key":"97406_CR78","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fimmu.2014.00476","volume":"5","author":"EC Castelli","year":"2014","unstructured":"Castelli, E. C. et al. Insights into HLA-G genetics provided by worldwide haplotype diversity. Front. Immunol. 5, 476 (2014).","journal-title":"Front. Immunol."},{"key":"97406_CR79","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/gene.2009.74","volume":"11","author":"EC Castelli","year":"2010","unstructured":"Castelli, E. C. et al. The genetic structure of 3\u2019untranslated region of the HLA-G gene: Polymorphisms and haplotypes. Genes Immun. 11, 134\u2013141 (2010).","journal-title":"Genes Immun."},{"key":"97406_CR80","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.humimm.2012.11.025","volume":"74","author":"ID Silva","year":"2013","unstructured":"Silva, I. D. et al. HLA-G 3\u2019UTR polymorphisms in high grade and invasive cervico-vaginal cancer. Hum. Immunol. 74, 452\u2013458 (2013).","journal-title":"Hum. Immunol."},{"key":"97406_CR81","first-page":"1441","volume":"121","author":"C Valenzuela","year":"1993","unstructured":"Valenzuela, C. 2 solutions for estimating odds ratios with zeros. Rev. Med. Chil. 121, 1441\u20131444 (1993).","journal-title":"Rev. Med. Chil."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97406-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97406-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97406-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T18:03:07Z","timestamp":1744912987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97406-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97406"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97406-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted following the principles outlined in the Declaration of Helsinki, following the approval granted by the relevant local Ethics Committee (Ethics Committee of the G. Brotzu Hospital in Cagliari, Italy; approval date: January 23, 2014; protocol number NP\/2014\/456). Written informed consent was acquired from all patients and is securely stored in the appropriate Medical Record Office.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"13331"}}